UVA Pioneering Artificial Pancreas to Undergo Final Tests
A device developed by UVa School of Medicine researchers to automatically monitor and regulate blood-sugar levels in people with type 1 diabetes will undergo final testing in two clinical trials.
Researchers at the University of Virginia School of Medicine are working to take the guesswork out of monitoring Type 1 diabetes.
Thanks to a new smart device, people could soon regulate their blood sugar levels automatically.
Using a smartphone, researchers are working relieve some of the burden facing patients with the disease.
"Everybody's looking for a cure for Type 1 diabetes, but in the meantime, we really have a lot of advancements in sensor technology, algorithms, and in pump technology," said Stacey Anderson, the associate professor of medicine at UVA Medical Center.
The application runs on what looks like your typically smartphone which is connected to the patient's blood glucose monitor and insulin pump.
"They are constantly having to count carbs, assess their actions, monitor their blood sugar multiple times a day, now this process will be much easier," said Anderson.
The application can adjust the insulin for the patient as well.
"If there is a prediction of the blood sugar going above 160 or less than 70, the algorithms automatically adjust the insulin for the patient," said Anderson.
TypeZero technologies is the licensor of the artificial pancreas.
"It runs on a five minute cycle and takes information from these devices and calculates the next best option for the patient pretty much any point in time,” said Chad Rogers, the ceo of TypeZero Technologies.
So far there has been extensive testing across the globe.
"In several sites, in Europe, here in the United States, we've been testing it very extensively for close to 180,000 hours of use so far across various people," said Boris Kovatchev, the director of UVA Center for Diabetes Technology.
Researchers are hopeful that this technology will eventually help people with both Type 1 diabetes and Type 2 diabetes.
Nearly 1.25 million Americans suffer from Type 1 diabetes.